Get started
Author

Jun‐Ting Tang

Observed names: Jun Ting Tang, Jun-Ting Tang, Junting Tang, Tang Jun-Ting, Tang Jun-ting
ORCID: 0000-0002-0530-4703
Observed ORCID: 0000-0002-0530-4703
OpenAlex ID: A5050412605
Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China
2019 · Yu‐Ye Li, Shi‐Han Yang, et al. · International Journal of Dermatology · 12
Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis
2025 · Jun Ting Tang, Ming Yuan Xu, et al. · International Journal of Dermatology · 11
PDF
Abrocitinib alleviates the symptoms of Netherton syndrome and is well tolerated
2025 · Jun-Ting Tang, Yu-Liang Qin, et al. · Journal of Dermatological Treatment · 7
ERK/STAT3 activation through CCL17/CCR4 axis-mediated type 2 cytokine-involved signaling pathways in Th2 cells regulates cutaneous drug reactions
2024 · Jun-Ting Tang, Kai-Cheng Gao, et al. · International Immunopharmacology · 6
HIV infection confers distinct mechanisms in severe drug eruption: Endogenous virus activation with aberrant Th2/Th1 and CD8 + T cells function
2020 · Jun‐Ting Tang, Yu‐Ye Li, et al. · Clinical and Experimental Pharmacology and Physiology · 6
Association of Human Leukocyte Antigen Alleles and Hypersensitivity of Efavirenz/Nevirapine in HIV-Infected Chinese Patients
2022 · Xiao-Yan Zhou, Chong-Xi Li, et al. · AIDS Research and Human Retroviruses · 4
Elevated Type 2 Inflammatory Factors, Th2/Th1 Balanced Status, and Exosomes as a Marker of Severity in Chronic Actinic Dermatitis
2025 · Tang Jun-Ting, Tu Ying, et al. · Mediators of Inflammation · 3
PDF
Successful Treatment of Mesotherapy Induced Granuloma Annulare With Baricitinib
2025 · Li Wang, Shang Shen Chen, et al. · Journal of Cosmetic Dermatology · 2
Effect of Epstein–Barr virus on macrophage M2 / M1 migration and EphA2 expression in adverse drug reactions
2024 · Ran An, Dong‐Jie Sun, et al. · The Journal of Dermatology · 2
Significance of HLA-B*15 in three pemphigus patients with rituximab-triggered severe cutaneous drug reactions
2024 · Tang Jun-ting, Tu Ying, et al. · Advances in Dermatology and Allergology · 2
PDF
Abrocitinib in the Treatment of Eruptive Pruritic Papular Porokeratosis: A Case Report
2025 · Shangshen Chen, Junting Tang, et al. · International Journal of Dermatology · 1
Baricitinib in the management of persistent actinic granuloma: An innovative therapeutic approach
2024 · Ran An, Junting Tang, et al. · Indian Journal of Dermatology Venereology and Leprology · 1
ART-Related Diseases in HIV/AIDS Patients
2020 · Lu-Hui Yang, Jun-Ting Tang, et al. · Springer eBooks · 1
Dupilumab Targeting IL ‐4/ IL ‐13 Pathway Improves RTK ‐ and PD ‐1‐Inhibitor‐Related Cutaneous Adverse Drug Reactions
2026 · Xiaoli Wang, Jun Ting Tang, et al. · Scandinavian Journal of Immunology
PDF
Purplish-brown Patches and Ecchymoses on the Dorsal Hands: A Quiz
2026 · Li Wang, Jun Ting Tang, et al. · Acta Dermato Venereologica
PDF
Author response for "HIV infection confers distinct mechanisms in severe drug eruption: endogenous virus activation with aberrant Th2/Th1 and CD8 + T cells function"
2020 · Jun‐Ting Tang, Yu‐Ye Li, et al. · Publons reviews and discussion
Author response for "HIV infection confers distinct mechanisms in severe drug eruption: endogenous virus activation with aberrant Th2/Th1 and CD8 + T cells function"
2019 · Jun‐Ting Tang, Yu‐Ye Li, et al. · Publons reviews and discussion
Works count: 17
Citation count: 58
H-index: 5
I10-index: 2
Year
Topic
Type